These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 1964564

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptors.
    Blauw GJ, van Brummelen P, Doorenbos CJ, van der Velde EA, van Zwieten PA.
    Clin Pharmacol Ther; 1991 Apr; 49(4):377-84. PubMed ID: 1849810
    [Abstract] [Full Text] [Related]

  • 12. Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients.
    Paolisso G, Gambardella A, Verza M, Varricchio M.
    Diabete Metab; 1990 Apr; 16(3):264-5. PubMed ID: 2210025
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
    Oren S, Turkot S, Paran E, Flandra O, Slezak L, Hof B.
    J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of ketanserin on glucose and lipid metabolism in diabetic patients with hypertension.
    Janka HU, Mehnert H, Fisher R, Seiler KU.
    Drugs; 1988 Feb; 36 Suppl 1():123-5. PubMed ID: 3240726
    [No Abstract] [Full Text] [Related]

  • 17. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
    Docherty JR.
    J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical and hemodynamic effects of medium-term treatment with ketanserin of 2 comparative groups of obese and non-obese hypertensive patients].
    Parrinello G.
    Ann Ital Med Int; 1990 Feb; 5(4 Pt 2):477-83. PubMed ID: 2102135
    [Abstract] [Full Text] [Related]

  • 20. Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patients.
    Gill JS, Al-Hussary N, Zezulka AV, Pasi KJ, Atkins TW, Beevers DG.
    Clin Ther; 1987 Feb; 9(3):304-10. PubMed ID: 3300989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.